Based on animal models where apoA-I overexpression and infusion inhibit plaque formation, it was hypothesized that infusion of apoA-I containing particles, such as lipid-poor pre-β HDL, would also have beneficial effects on plaque stabilization and atherosclerosis regression. Here, APOA1 is linked to atherosclerosis.